Both in Pharmaceuticals
Organon & vs Xenon Pharmaceuticals
Over the past year OGN returned +32.8% and XENE returned −4.6%; their daily moves had a correlation of 0.00.
OGN +32.8% XENE −4.6%Growth of $1, one year, split-adjusted
| Metric | OGN | XENE |
|---|---|---|
| Price | $13.74 | $37.25 |
| Market cap | $3.61B | $3.61B |
| Today | +0.07% | +1.44% |
| 1 month | −0.1% | −37.9% |
| 6 months | +141.1% | −32.9% |
| Year to date | +91.6% | −16.9% |
| 1 year | +34.6% | −1.9% |
| Revenue growth (YoY) | −2.3% | — |
| Gross margin | 54.4% | — |
| Net margin | 6.9% | — |
| P/E (TTM) | 17.3× | — |
| Price / sales | 0.6× | — |
| Net cash | -$7.42B | $930.7M |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.8% | 84.0% |
| Short % of float | 6.7% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).